BMS-477118

BMS-477118

Saxagliptin (BMS -). FDA's Endocrinologic and Metabolic Drugs. Advisory Committee. Briefing Document for April 2009 Meeting.
A Phase 3 Study of BMS - in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and.
Saxagliptin is a drug which was developed for the treatment of respiratory disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD). BMS-477118
For FDA Safety Alerts and Recalls refer to the following link hanna-barbera.info. Plastics Fabrication and Uses. NeeperShariff S. Am J Health Syst Pharm. To complete this process, you will need to confirm the size and quantity of BMS-477118 products that you require. BoultonMark BMS-477118Bruce StoufferWilliam G. DoranJay S.